Cervical Lesion
16
3
5
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
1 terminated out of 16 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
Evaluating Universal Adhesives in Cervical Lesions
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
Impact of Catch-up HPV Vaccination
Stability and Function of Cervical Spine With Grade Point Average in University Students
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
Bioactive Restorative Material in Non-Carious Cervical Lesions
Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care
RWE Study in the Treatment of Cervical Lesions of Various Etiology
See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia
Clinical Evaluation of Bulk-fill Alkasite Restoration Versus Resin Modified Glass Ionomer in Adult With Class V Carious
Bioactive Glass Air-abrasion and Non-carious Cervical Lesions
Colposcopy and Dynamic Spectral Imaging (DSI)
Risk Predictors of Extubation Failure for Cervico-medullary Junction Surgery